Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder

• Status: Completed
• Trial end date: 2013-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The study will evaluate the efficacy of agomelatine compared to placebo on the reduction of Obsessive and Compulsive symptoms after 16 weeks of treatment.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Institut de Recherches Internationales Servier; Servier
• Treatments: S 20098

Criteria

Inclusion Criteria:

• Obsessive Compulsive Disorder (OCD) according to Diagnostic and Statistical Manual, Fourth Edition, Text Revision (DSM-IV-TR),

• Y-BOCS total score ≥ 20,

• duration of OCD symptoms of at least one year.

Exclusion Criteria:

• Bipolar disorder, Schizophrenic or Psychotic Disorder

• Severe or uncontrolled organic diseases

• Neurological disorder

• Women of childbearing potential who are not using effective contraception